ZFIN ID: ZDB-FISH-150901-10561
Fish name: per1bsus001Tg/sus001Tg
Genotype: per1bsus001Tg/sus001Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by per1bsus001Tg/sus001Tg
Human Disease Conditions Citations
attention deficit hyperactivity disorder standard conditions Huang et al., 2015
GENE EXPRESSION
Gene expression in per1bsus001Tg/sus001Tg
RNA expression
Expressed Gene Structure Conditions Figures
atg4a constant dark Fig. 5 from Huang et al., 2016
atp6v1d constant dark Fig. 5 from Huang et al., 2016
becn1 constant dark Fig. 5 from Huang et al., 2016
bnip3 constant dark Fig. 5 from Huang et al., 2016
cebpb constant dark Fig. 5 from Huang et al., 2016
gabarapa constant dark Fig. 5 from Huang et al., 2016
map1lc3b constant dark Fig. 5 from Huang et al., 2016
per1b standard conditions Fig. 2 from Huang et al., 2015
ulk1a constant dark Fig. 5 from Huang et al., 2016
ulk1b constant dark Fig. 5 from Huang et al., 2016
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab1-per1b per1b standard conditions Fig. 2 from Huang et al., 2015
Reporter gene expression No data available
PHENOTYPE
Phenotype in per1bsus001Tg/sus001Tg
Phenotype Conditions Figures
behavior process quality, abnormal standard conditions Fig. 3Fig. 9 from Huang et al., 2015
behavior process quality, ameliorated chemical treatment: methylphenidate Fig. 9 from Huang et al., 2015
behavior process quality, ameliorated chemical treatment: (-)-selegiline Fig. 9 from Huang et al., 2015
caudal tuberculum has fewer parts of type dopaminergic neuron, abnormal standard conditions Fig. 6Fig. 7 from Huang et al., 2015
caudal tuberculum dopaminergic neuron disorganized, abnormal standard conditions Fig. 6 from Huang et al., 2015
circadian rhythm rhythm quality, abnormal standard conditions Fig. 2 from Huang et al., 2015
learning decreased process quality, abnormal standard conditions Fig. 3 from Huang et al., 2015
learning process quality, abnormal standard conditions Fig. 3 from Huang et al., 2015
locomotory behavior increased process quality, abnormal standard conditions Fig. 2Fig. 3Fig. 9 from Huang et al., 2015
locomotory behavior process quality, ameliorated chemical treatment: (-)-selegiline Fig. 9 from Huang et al., 2015
locomotory behavior process quality, ameliorated chemical treatment: methylphenidate Fig. 9 from Huang et al., 2015
locomotory exploration behavior increased process quality, abnormal standard conditions Fig. 3 from Huang et al., 2015
memory decreased process quality, abnormal standard conditions Fig. 3 from Huang et al., 2015
whole organism map1lc3b expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016
whole organism gabarapa expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016
whole organism ulk1a expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016
whole organism atg4a expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016
whole organism ulk1b expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016
whole organism bnip3 expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016
whole organism cebpb expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016
whole organism becn1 expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016
whole organism atp6v1d expression increased amount, abnormal constant dark Fig. 5 from Huang et al., 2016

CITATIONS  (5)